1
|
Mangesius J, Seppi T, Ibrahim R, Fleischmann K, Ginestet A, Vorbach S, Hart T, Pointner M, Mangesius S, Ganswindt U. Dynamic intrafractional position monitoring with implanted fiducial markers for enhanced accuracy in radiotherapy of prostate cancer. Phys Eng Sci Med 2023; 46:1365-1374. [PMID: 37523057 PMCID: PMC10703977 DOI: 10.1007/s13246-023-01304-w] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2023] [Accepted: 07/16/2023] [Indexed: 08/01/2023]
Abstract
INTRODUCTION Recent advances in the radiation therapy of prostate cancer have brought a shift toward moderate- and ultra-hypofractionated treatment schedules. Reducing safety margins can broaden the therapeutic window in stereotactic treatments and alleviate concerns for toxicity in high dose-per-fraction treatment schedules. Management of intrafractional motion is a necessity for stereotactic body radiation therapy (SBRT). It can be achieved by performing intrafractional image guidance and position corrections. We evaluate the suitability of such a novel prostate motion management system and its potential benefit for treatment accuracy. METHODS Intrafractional IGRT was performed for 22 patients during 149 treatment sessions using repeated orthogonal kV-XR imaging of implanted fiducial markers with the ExacTrac Dynamic (EXTD) system. Position measurements were taken four times during each arc of the applied volumetric modulated arc therapy (VMAT). Position correction was performed if translational deviation exceeded 2 mm in any direction. RESULTS Of 677 single EXTD measurements, 20.6% exceeded the predefined threshold of 2 mm 3D deviation. Without intrafractional corrections, 39.4% of all individual measurements would exceed the threshold. The 3D accuracy could thus significantly be improved, reducing mean 3D shifts from 1.97 (± 1.44) mm to 1.39 (± 1.01) mm by performing intrafractional IGRT. In total, 34% of all treatment sessions required correction of intrafractional position shifts. CONCLUSION Monitoring of prostate motion using repeated intrafractional orthogonal kV-X-ray-based position measurements of implanted fiducial markers proved to be a reliable method to improve precision of stereotactic irradiations of the prostate. It can prevent unacceptable translation deviations in one third of all sessions.
Collapse
Affiliation(s)
- Julian Mangesius
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria.
| | - Thomas Seppi
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| | - Ramine Ibrahim
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| | - Katrin Fleischmann
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| | - Angela Ginestet
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| | - Samuel Vorbach
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| | - Tilmann Hart
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| | - Martin Pointner
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| | - Stephanie Mangesius
- Department of Neuroradiology, Medical University of Innsbruck, Innsbruck, Austria
| | - Ute Ganswindt
- Department of Radiation Oncology, Medical University of Innsbruck, Univ.-Klinik für Strahlentherapie-Radioonkologie, Anichstrasse 35, Innsbruck, 6020, Austria
| |
Collapse
|
2
|
Arumugam S, Wong K, Do V, Sidhom M. Reducing the margin in prostate radiotherapy: optimizing radiotherapy with a general-purpose linear accelerator using an in-house position monitoring system. Front Oncol 2023; 13:1116999. [PMID: 37519807 PMCID: PMC10373585 DOI: 10.3389/fonc.2023.1116999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Accepted: 06/27/2023] [Indexed: 08/01/2023] Open
Abstract
Purpose To study the feasibility of optimizing the Clinical Target Volume to Planning Target Volume (CTV-PTV) margin in prostate radiotherapy(RT) with a general-purpose linear accelerator using an in-house developed position monitoring system, SeedTracker. Methods A cohort of 30 patients having definitive prostate radiotherapy treated within an ethics-approved prospective trial was considered for this study. The intrafraction prostate motion and the position deviations were measured using SeedTracker system during each treatment fraction. Using this data the CTV-PTV margin required to cover 90% of the patients with a minimum of 95% of the prescription dose to CTV was calculated using van Herk's formula. The margin calculations were performed for treatment scenarios both with and without applying the position corrections for observed position deviations. The feasibility of margin reduction with real-time monitoring was studied by assessing the delivered dose that incorporates the actual target position during treatment delivery and comparing it with the planned dose. This assessment was performed for plans generated with reduced CTV-PTV margin in the range of 7mm-3mm. Results With real-time monitoring and position corrections applied the margin of 2.0mm, 2.1mm and 2.1mm in LR, AP and SI directions were required to meet the criteria of 90% population to receive 95% of the dose prescription to CTV. Without position corrections applied for observed position deviations a margin of 3.1mm, 4.0mm and 3.0mm was required in LR, AP and SI directions to meet the same criteria. A mean ± SD reduction of 0.5 ± 1.8% and 3 ± 7% of V60 for the rectum and bladder can be achieved for every 1mm reduction of PTV margin. With position corrections applied, the CTV D99 can be delivered within -0.2 ± 0.3 Gy of the planned dose for plans with a 3mm margin. Without applying corrections for position deviations the CTV D99 was reduced by a maximum of 1.1 ± 1.1 Gy for the 3mm margin plan and there was a statistically significant difference between planned and delivered dose for 3mm and 4mm margin plans. Conclusion This study demonstrates the feasibility of reducing the margin in prostate radiotherapy with SeedTracker system without compromising the dose delivery accuracy to CTV while reducing dose to critical structures.
Collapse
Affiliation(s)
- Sankar Arumugam
- Department of Medical Physics, Liverpool and Macarthur Cancer Therapy Centres and Ingham Institute, Sydney, NSW, Australia
- South Western Clinical School, University of New South Wales, Sydney, NSW, Australia
| | - Karen Wong
- South Western Clinical School, University of New South Wales, Sydney, NSW, Australia
- Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, Sydney, NSW, Australia
| | - Viet Do
- South Western Clinical School, University of New South Wales, Sydney, NSW, Australia
- Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, Sydney, NSW, Australia
| | - Mark Sidhom
- South Western Clinical School, University of New South Wales, Sydney, NSW, Australia
- Department of Radiation Oncology, Liverpool and Macarthur Cancer Therapy Centres, Sydney, NSW, Australia
| |
Collapse
|
3
|
Sun X, Dai Z, Xu M, Guo X, Su H, Li Y. Quantifying 6D tumor motion and calculating PTV margins during liver stereotactic radiotherapy with fiducial tracking. Front Oncol 2022; 12:1021119. [DOI: 10.3389/fonc.2022.1021119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2022] [Accepted: 10/18/2022] [Indexed: 11/18/2022] Open
Abstract
ObjectiveOur study aims to estimate intra-fraction six-dimensional (6D) tumor motion with rotational correction and the related correlations between motions of different degrees of freedom (DoF), as well as quantify sufficient anisotropic clinical target volume (CTV) to planning target volume (PTV) margins during stereotactic body radiotherapy (SBRT) of liver cancer with fiducial tracking technique.MethodsA cohort of 12 patients who were implanted with 3 or 4 golden markers were included in this study, and 495 orthogonal kilovoltage (kV) pairs of images acquired during the first fraction were used to extract the spacial position of each golden marker. Translational and rotational motions of tumor were calculated based on the marker coordinates by using an iterative closest point (ICP) algorithm. Moreover, the Pearson product-moment correlation coefficients (r) were applied to quantify the correlations between motions with different degrees of freedom (DoFs). The population mean displacement (MP¯), systematic error (Σ) and random error (σ) were obtained to calculate PTV margins based on published recipes.ResultsThe mean translational variability of tumors were 0.56, 1.24 and 3.38 mm in the left-right (LR, X), anterior-posterior (AP, Y), and superior-inferior (SI, Z) directions, respectively. The average rotational angles θX , θY and θZ around the three coordinate axes were 0.88, 1.24 and 1.12, respectively. (|r|>0.4) was obtainted between Y -Z , Y - θZ , Z -θZ and θX - θY . The PTV margins calculated based on 13 published recipes in X, Y, and Z directions were 1.08, 2.26 and 5.42 mm, and the 95% confidence interval (CI) of them were (0.88,1.28), (1.99,2.53) and (4.78,6.05), respectively.ConclusionsThe maximum translational motion was in SI direction, and the largest correlation coefficient of Y-Z was obtained. We recommend margins of 2, 3 and 7 mm in LR, AP and SI directions, respectively.
Collapse
|
4
|
Jordan B, Muñoz L, Colyer C. Reducing ExacTrac intrafraction imaging uncertainty for prostate stereotactic body radiotherapy using a pre-treatment CBCT. Phys Eng Sci Med 2022; 45:547-558. [PMID: 35438452 DOI: 10.1007/s13246-022-01121-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/27/2021] [Accepted: 03/24/2022] [Indexed: 10/18/2022]
Abstract
This study evaluated the intrafractional auto-matching uncertainties of prostate-implanted fiducial markers when using the ExacTrac v6.5 (Brainlab, Feldkirchen, Germany) X-ray stereoscopic system. A customised phantom with 3 implanted gold seeds was initially positioned at the isocentre using a cone beam CT (CBCT) prior to intrafractional imaging. Progressive offsets were applied to the phantom in all six directions (3 translational, 3 rotational) of 0 mm, 1 mm, 2 mm, 0°, 1° and 2°. Subsequently, the ability of the ExacTrac image-matching functions to detect and correct these offsets was tested. For comparison, this procedure was repeated, but without a CBCT for pre-treatment positioning. The auto-matching uncertainties when a CBCT was introduced into the workflow were significantly reduced, and overall, the auto-matching statistics using the implanted marker (seeds) matching function was found to be more precise than the bony anatomy function in-phantom. The total standard deviations for the translational shifts using the implanted marker and bony anatomy functions respectively were 0.1 mm and 0.3 mm vertically, 0.1 mm and 0.3 mm longitudinally, and 0.1 mm and 0.4 mm laterally. The standard deviations for the rotational shifts using the implanted marker and bony anatomy matching functions respectively were 0.2° and 1.2° for the yaw (angle vert), 0.3° and 1.1° for the pitch (angle long), and 0.2° and 1.2° for the roll (angle lat) directions. The reduced uncertainties from introducing a CBCT for initial localisation resulted in decreased probability of inhibits due to false positives during treatment.
Collapse
Affiliation(s)
- Barry Jordan
- GenesisCare, St. Andrew's Hospital Oncology, Adelaide, SA, Australia.
| | - Luis Muñoz
- GenesisCare, St. Andrew's Hospital Oncology, Adelaide, SA, Australia
| | | |
Collapse
|
5
|
Zhang L, LoSasso T, Zhang P, Hunt M, Mageras G, Tang G. Couch and multileaf collimator tracking: A clinical feasibility study for pancreas and liver treatment. Med Phys 2020; 47:4743-4757. [PMID: 32757298 PMCID: PMC8330968 DOI: 10.1002/mp.14438] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2020] [Revised: 07/13/2020] [Accepted: 07/14/2020] [Indexed: 12/25/2022] Open
Abstract
PURPOSE Real-time tumor tracking through active correction by the multileaf collimator or treatment couch offers a promising strategy to mitigate delivery uncertainty due to intrafractional tumor motion. This study evaluated the performance of MLC and couch tracking using the prototype iTools Tracking system in TrueBeam Developer Mode and the application for abdominal cancer treatments. METHODS Experiments were carried out using a phantom with embedded Calypso transponders and a motion simulation platform. Geometric evaluations were performed using a circular conformal field with sinusoidal traces and pancreatic tumor motion traces. Geometric tracking accuracy was retrospectively calculated by comparing the compensational MLC or couch motion extracted from machine log files to the target motion reconstructed from real-time MV and kV images. Dosimetric tracking accuracy was measured with radiochromic films using clinical abdominal VMAT plans and pancreatic tumor traces. RESULTS Geometrically, the root-mean-square errors for MLC tracking were 0.5 and 1.8 mm parallel and perpendicular to leaf travel direction, respectively. Couch tracking, in contrast, showed an average of 0.8 mm or less geometric error in all directions. Dosimetrically, both MLC and couch tracking reduced motion-induced local dose errors compared to no tracking. Evaluated with five pancreatic tumor motion traces, the average 2%/2 mm global gamma pass rate of eight clinical abdominal VMAT plans was 67.4% (range: 26.4%-92.7%) without tracking, which was improved to 86.0% (range: 67.9%-95.6%) with MLC tracking, and 98.1% (range: 94.9%-100.0%) with couch tracking. In 16 out of 40 deliveries with different plans and motion traces, MLC tracking did not achieve clinically acceptable dosimetric accuracy with 3%/3mm gamma pass rate below 95%. CONCLUSIONS This study demonstrated the capability of MLC and couch tracking to reduce motion-induced dose errors in abdominal cases using a prototype tracking system. Clinically significant dose errors were observed with MLC tracking for certain plans which could be attributed to the inferior MLC tracking accuracy in the direction perpendicular to leaf travel, as well as the interplay between motion tracking and plan delivery for highly modulated plans. Couch tracking outperformed MLC tracking with consistently high dosimetric accuracy in all plans evaluated, indicating its clinical potential in the treatment of abdominal cancers.
Collapse
Affiliation(s)
- Lei Zhang
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
| | - Thomas LoSasso
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
| | - Pengpeng Zhang
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
| | - Margie Hunt
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
| | - Gig Mageras
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
| | - Grace Tang
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA
| |
Collapse
|
6
|
López-Torrecilla J, Pastor-Peidro J, Vicedo-González A, González-Sanchis D, Hernandez-Machancoses A, Almendros-Blanco P, García-Miragall E, Gordo-Partearroyo JC, García-Hernández T, Brualla-González L, Granero-Cabañero D, Rosello-Ferrando J. Patterns of treatment failure in patients with prostate cancer treated with 76-80 Gy radiotherapy to the prostate and seminal vesicles ± hormonotherapy. Clin Transl Oncol 2020; 23:481-490. [PMID: 32621208 DOI: 10.1007/s12094-020-02437-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/28/2020] [Accepted: 06/19/2020] [Indexed: 01/13/2023]
Abstract
PURPOSE To assess the pattern of treatment failure in patients with prostate cancer (PCa) treated with radiotherapy (76-80 Gy) ± hormone therapy (HT). We also evaluated the influence of treatment failure on survival outcomes. METHODS Retrospective study of patients with PCa (n = 302) treated with radiotherapy (RT) ± HT at our centre between November 1999 and July 2007. The mean patient age was 70.2 years (range 51-87). Distribution by NCCN risk group was low (n = 80, 26.5%), intermediate (n = 86, 28.5%), high (n = 77, 25.5%), and very high (n = 49, 16.2%). Most patients (n = 273, 90.4%) received IMRT at a dose of 76-80 Gy. HT was administered in 237 patients (78.5%), in most cases (n = 167, 55.3%) for < 7 months RESULTS: Survival rates at 10 years were: overall survival (OS), 64.3%; biochemical disease-free survival, 83.9%; disease-free survival, 92.5%; and metastasis-free survival (MFS), 94.3%. Biochemical failure (BF) was observed in 55 cases (18.2%), 32 of whom subsequently developed clinical recurrence: metastasis (n = 17, 5.6%), local failure (n = 11, 3.6%), and regional failure (n = 4, 1.3%). The cause of death (n = 159) was intercurrent disease in 115 cases (72.3%), second cancer in 27 (17.0%), and PCa in 17 (10.7%). Biochemical failure-free survival ≤ 24 months was significantly associated with worse OS and MFS (p = 0.0001). Late genitourinary and gastrointestinal toxicity grade ≥ 3 (RTOG) was observed in 18 (6.0%) and 7 (2.3%) patients, respectively. CONCLUSIONS The main type of treatment failure after 76-80 Gy of radiotherapy ± HT is local or metastatic. In all cases, biochemical failure occurred prior to treatment failure. BF within 24 months of treatment completion was significantly associated with worse OS and MFS.
Collapse
Affiliation(s)
- J López-Torrecilla
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain.
| | - J Pastor-Peidro
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - A Vicedo-González
- Medical Physics Department, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - D González-Sanchis
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - A Hernandez-Machancoses
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - P Almendros-Blanco
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - E García-Miragall
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - J C Gordo-Partearroyo
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - T García-Hernández
- Department of Radiation Oncology, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain.,Medical Physics Department, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - L Brualla-González
- Medical Physics Department, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - D Granero-Cabañero
- Medical Physics Department, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| | - J Rosello-Ferrando
- Medical Physics Department, ERESA, Hospital General Universitario de Valencia, Av. Tres Cruces, 2, 46014, Valencia, Spain
| |
Collapse
|
7
|
Rijken J, Sidhom M. An assessment of the ExacTrac intrafraction imaging capabilities for flattening filter free prostate stereotactic body radiotherapy. Phys Eng Sci Med 2020; 43:849-855. [PMID: 32557247 DOI: 10.1007/s13246-020-00884-1] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2019] [Accepted: 05/31/2020] [Indexed: 12/31/2022]
Abstract
The uncertainties associated with image matching using the ExacTrac® system (BrainLab, Munich, Germany) have been the subject of investigation in the literature for extra-cranial sites. However, the uncertainties involved in the use of ExacTrac in the presence of higher scatter conditions like that for intrafraction imaging of prostate stereotactic radiotherapy utilising unflattened beams is yet to be determined. A prostate phantom was created with 3 implanted gold fiducial markers. This phantom was shifted by 1 mm and 2 mm amounts in the translational planes and by 1° and 2° amounts in the rotational planes and subsequently imaged by ExacTrac during delivery of a clinical SBRT plan. ExacTrac auto-match results were compared to the known offsets with uncertainties calculated. Calculated shifts were shown to be accurate within one standard deviation of the known offsets. Uncertainties were found to vary considerably among the 6 dimensions with matching in the vertical and angle vertical directions having standard deviations of 0.7 mm and 1.3°, respectively. These results agreed with the literature cases for pre-treatment setup and lower scatter condition IMRT intrafraction delivery. Based on these values, probabilities of intrafraction inhibits were calculated based on patient movement and possible fusion tolerances. While the measured uncertainties are adequately defined in order to calculate appropriate target margins, their relatively large magnitudes made choice of intrafraction fusion tolerances problematic. A degree of compromise between the rate of false positives and false negatives is required when implementing ExacTrac into a SBRT prostate protocol.
Collapse
Affiliation(s)
- James Rijken
- Icon Cancer Centre, 480 Specialist Centre, Windsor Gardens, SA, Australia. .,Queensland University of Technology, Brisbane, QLD, Australia.
| | - Mark Sidhom
- GenesisCare, Waratah Private Hospital, Hurstville, NSW, Australia.,University of New South Wales, Sydney, NSW, Australia
| |
Collapse
|
8
|
Gorovets D, Burleson S, Jacobs L, Ravindranath B, Tierney K, Kollmeier M, McBride S, Happersett L, Hunt M, Zelefsky M. Prostate SBRT With Intrafraction Motion Management Using a Novel Linear Accelerator-Based MV-kV Imaging Method. Pract Radiat Oncol 2020; 10:e388-e396. [PMID: 32454176 DOI: 10.1016/j.prro.2020.04.013] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2019] [Revised: 04/19/2020] [Accepted: 04/24/2020] [Indexed: 01/10/2023]
Abstract
PURPOSE This study reports clinical experience using a linear accelerator-based MV-kV imaging system for intrafraction motion management during prostate stereotactic body radiation therapy (SBRT). METHODS AND MATERIALS From June 2016 to August 2018, 193 prostate SBRT patients were treated using MV-kV motion management (median dose 40 Gy in 5 fractions). Patients had 3 fiducials implanted then simulated and treated with a full bladder and empty rectum. Pretreatment orthogonal kVs and cone beam computed tomography were used to position patients and evaluate internal anatomy. Motion was tracked during volumetric modulated arc therapy delivery using simultaneously acquired kV and MV images from standard on-board systems. Treatment was interrupted to reposition patients when motion >1.5-2 mm was detected. Motion traces were analyzed and compared with Calypso traces from a previously treated similar patient cohort. To evaluate "natural motion" (ie, if we had not interrupted treatment and repositioned), intrafraction couch corrections were removed from all traces. Clinical effectiveness of the MV-kV system was explored by evaluating toxicity (Common Terminology Criteria for Adverse Events v3.0) and biochemical recurrence rates (nadir + 2 ng/mL). RESULTS Median number of interruptions for patient repositioning was 1 per fraction (range, 0-9). Median overall treatment time was 8.2 minutes (range, 4.2-44.8 minutes). Predominant motion was inferior and posterior, and probability of motion increased with time. Natural motion >3 mm and >5 mm in any direction was observed in 32.3% and 10.2% of fractions, respectively. Calypso monitoring (n = 50) demonstrated similar motion results. In the 151 MV-kV patients with ≥3-month follow-up (median, 9.5 months; range, 3-26.5 months), grade ≥2 acute genitourinary/gastrointestinal and late genitourinary/gastrointestinal toxicity was observed in 9.9%/2.0% and 11.9%/2.7%, respectively. Biochemical control was 99.3% with a single failure in a high-risk patient. CONCLUSIONS The MV-kV system is an effective method to manage intrafraction prostate motion during SBRT, offering the opportunity to correct for prostate clinical target volume displacements that would have otherwise extended beyond typical planning target volume margins.
Collapse
Affiliation(s)
- Daniel Gorovets
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
| | - Sarah Burleson
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Lauren Jacobs
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Bosky Ravindranath
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Kevin Tierney
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Marisa Kollmeier
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Sean McBride
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Laura Happersett
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Margie Hunt
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York
| | - Michael Zelefsky
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York
| |
Collapse
|
9
|
Chasseray M, Dissaux G, Lucia F, Boussion N, Goasduff G, Pradier O, Bourbonne V, Schick U. Kilovoltage intrafraction monitoring during normofractionated prostate cancer radiotherapy. Cancer Radiother 2020; 24:99-105. [PMID: 32201058 DOI: 10.1016/j.canrad.2019.11.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2019] [Revised: 11/18/2019] [Accepted: 11/23/2019] [Indexed: 02/07/2023]
Abstract
PURPOSE During radiotherapy (RT) for prostate cancer (PCa), interfraction and intrafraction movements can lead to decreased target dose coverage and unnecessary over-exposure of organs at risk. New image-guided RT techniques accuracy allows planning target volume (PTV) margins reduction. We aim to assess the feasibility of a kilovoltage intrafraction monitoring (KIM) to track the prostate during RT. METHODS AND MATERIALS Between November 2017 and April 2018, 44 consecutive patients with PCa were included in an intrafraction prostate motion study using the Truebeam Auto Beam Hold® tracking system (Varian Medical Systems, United State) triggered by gold fiducials localization on kilovoltage (kV) imaging. A 5-mm PTV was considered. A significant gating event (SGE) was defined as the occurrence of an automatic beam interruption requiring patient repositioning following the detection of one fiducial outside a 5-mm target area around the marker during more than 45seconds. RESULTS Six patients could not benefit from the KIM because of technical issues (loss of one fiducial marker=1, hip prosthesis=4, morbid obesity causing table movements=1). The mean rate of SGE per patient was 14±19%, and the fraction average delivery time was increased by 146±86seconds. For a plan of 39 fractions of 2Gy, the additional radiation dose increased by 0.13±0.09Gy. The mean rates of SGE were 2% and 18% (P=0.002) in patients with planned fraction<90 and>90seconds respectively, showing that duration of the session strongly interfered with prostate intrafraction movements. No other significant clinical and technical parameter was correlated with the occurrence of SGE. CONCLUSION Automated intrafraction kV imaging can effectively perform autobeam holds due to intrafraction movement of the prostate in the large majority of patients. The additional radiation dose and delivery time are acceptable. This technique may be a cost-effective alternative to electromagnetic transponder guidance.
Collapse
Affiliation(s)
- M Chasseray
- Radiation Oncology Department, CHU de Brest, Brest, France
| | - G Dissaux
- Radiation Oncology Department, CHU de Brest, Brest, France; LaTIM, INSERM, UMR 1101, CHRU de Brest, Brest, France
| | - F Lucia
- Radiation Oncology Department, CHU de Brest, Brest, France
| | - N Boussion
- Radiation Oncology Department, CHU de Brest, Brest, France; LaTIM, INSERM, UMR 1101, CHRU de Brest, Brest, France
| | - G Goasduff
- Radiation Oncology Department, CHU de Brest, Brest, France
| | - O Pradier
- Radiation Oncology Department, CHU de Brest, Brest, France; LaTIM, INSERM, UMR 1101, CHRU de Brest, Brest, France; Faculté de médecine et des sciences de la santé, université de Bretagne Occidentale, Brest, France
| | - V Bourbonne
- Radiation Oncology Department, CHU de Brest, Brest, France
| | - U Schick
- Radiation Oncology Department, CHU de Brest, Brest, France; LaTIM, INSERM, UMR 1101, CHRU de Brest, Brest, France; Faculté de médecine et des sciences de la santé, université de Bretagne Occidentale, Brest, France.
| |
Collapse
|
10
|
Choi HS, Kang KM, Jeong BK, Song JH, Lee YH, Ha IB, Kam SC, Hwa JS, Hyun JS, Do J, Jeong DH, Jeong H. Analysis of Motion-dependent Clinical Outcome of Tumor Tracking Stereotactic Body Radiotherapy for Prostate Cancer. J Korean Med Sci 2018; 33:e107. [PMID: 29607633 PMCID: PMC5879038 DOI: 10.3346/jkms.2018.33.e107] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 01/26/2018] [Indexed: 12/25/2022] Open
Abstract
BACKGROUND To analyze clinical outcome of CyberKnife (CK) tumor-tracking stereotactic body radiotherapy (SBRT) for prostate cancer (Pca) according to the magnitude of intra-fractional prostate motion. METHODS Medical records and daily treatment logs for 71 patients who received CK tumor-tracking SBRT were retrospectively analyzed. Statistical relationships between prostate motion and various outcome results, including local recurrence (LR), biochemical failure (BF), and treatment-related toxicity, were investigated in order to evaluate motion-dependent efficacy of tumor-tracking SBRT for Pca. RESULTS In a total 71 patients, 3 (4.2%) patients with LR, 12 (16.9%) patients with BF, and 22 (31%) patients with grade-II or worse toxicities to rectal or bladder (22 to rectal, 22 to bladder and 8 patients to both) were observed in a median follow-up of 47 months. Magnitudes of intra-fractional tumor motion along superior-inferior, right-left, and anterior-posterior (AP) axes were 0.15 ± 0.31, 0.12 ± 0.19, and 0.73 ± 0.32 mm, respectively. Radial magnitude was estimated to be 1.0 ± 0.35 mm. Intra-fractional movement was not significantly correlated with tumor control. However, it was significant correlated with the incidence of grade-II or worse toxicity to rectum or bladder particularly when tumor motion was in the AP axis. CONCLUSION Our quantitative results revealed that toxicity related to SBRT treatment was highly sensitive to intra-fractional prostate movements, although local-tumor control was not affected by such movements. Our results demonstrate that precise motion correction is essential in prostate SBRT, even if it seems to be small.
Collapse
Affiliation(s)
- Hoon Sik Choi
- Department of Radiation Oncology, Gyeongsang National University School of Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea
| | - Ki Mun Kang
- Department of Radiation Oncology, Gyeongsang National University School of Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
| | - Bae Kwon Jeong
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
- Department of Radiation Oncology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea
| | - Jin Ho Song
- Department of Radiation Oncology, Gyeongsang National University School of Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
| | - Yun Hee Lee
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
- Department of Radiation Oncology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea
| | - In Bong Ha
- Department of Radiation Oncology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea
| | - Sung Chul Kam
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
- Department of Urology, Gyeongsang National University School of Medicine, Gyeongsang National University Changwon Hospital, Changwon, Korea
| | - Jeong Seok Hwa
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
- Department of Urology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea
| | - Jae Seog Hyun
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
- Department of Urology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea
| | - Jungmo Do
- Department of Urology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea
| | - Dong Hyeok Jeong
- Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Korea
| | - Hojin Jeong
- Institute of Health Science, Gyeongsang National University, Jinju, Korea
- Department of Radiation Oncology, Gyeongsang National University School of Medicine, Gyeongsang National University Hospital, Jinju, Korea.
| |
Collapse
|
11
|
Hunt MA, Sonnick M, Pham H, Regmi R, Xiong JP, Morf D, Mageras GS, Zelefsky M, Zhang P. Simultaneous MV-kV imaging for intrafractional motion management during volumetric-modulated arc therapy delivery. J Appl Clin Med Phys 2016; 17:473-486. [PMID: 27074467 PMCID: PMC4831078 DOI: 10.1120/jacmp.v17i2.5836] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2015] [Revised: 12/06/2015] [Accepted: 11/20/2015] [Indexed: 11/23/2022] Open
Abstract
The purpose of this study was to evaluate the accuracy and clinical feasibility of a motion monitoring method employing simultaneously acquired MV and kV images during volumetric-modulated arc therapy (VMAT). Short-arc digital tomosynthesis (SA-DTS) is used to improve the quality of the MV images that are then combined with orthogonally acquired kV images to assess 3D motion. An anthropomorphic phantom with implanted gold seeds was used to assess accuracy of the method under static, typical prostatic, and respiratory motion scenarios. Automatic registra-tion of kV images and single MV frames or MV SA-DTS reconstructed with arc lengths from 2° to 7° with the appropriate reference fiducial template images was performed using special purpose-built software. Clinical feasibility was evaluated by retrospectively analyzing images acquired over four or five sessions for each of three patients undergoing hypofractionated prostate radiotherapy. The standard deviation of the registration error in phantom using MV SA-DTS was similar to single MV images for the static and prostate motion scenarios (σ = 0.25 mm). Under respiratory motion conditions, the standard deviation of the registration error increased to 0.7mm and 1.7 mm for single MV and MV SA-DTS, respectively. Registration failures were observed with the respiratory scenario only and were due to motion-induced fiducial blurring. For the three patients studied, the mean and standard deviation of the difference between automatic registration using 4° MV SA-DTS and manual registration using single MV images results was 0.07±0.52mm. The MV SA-DTS results in patients were, on average, superior to single-frame MV by nearly 1 mm - significantly more than what was observed in phantom. The best MV SA-DTS results were observed with arc lengths of 3° to 4°. Registration failures in patients using MV SA-DTS were primarily due to blockage of the gold seeds by the MLC. The failure rate varied from 2% to 16%. Combined MV SA-DTS and kV imaging is feasible for intratreatment motion monitoring during VMAT of anatomic sites where limited motion is expected, and improves registration accuracy compared to single MV/kV frames. To create a clinically robust technique, further improvements to ensure visualization of fiducials at the desired control points without degradation of the treatment plan are needed.
Collapse
|
12
|
Image-Guided Radiotherapy for Prostate Cancer using 3 Different Techniques: Localization Data of 186 Patients. TUMORI JOURNAL 2015; 101:273-80. [DOI: 10.5301/tj.5000322] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/14/2015] [Indexed: 11/20/2022]
Abstract
Aims and Background This study evaluates 3 different imaging modalities—ultrasound (US), stereoscopic X-ray imaging of implanted markers (Visicoils) (X-ray), and kV cone-beam computed tomography (CBCT)—to assess interfraction and intrafraction localization error during conformal radiation therapy of prostate cancer. Methods and Study Design The study population consisted of 186 consecutive prostate cancer patients treated with an image-guided radiotherapy (IGRT) hypofractionated protocol using 3 techniques: 32 with X-ray, 30 with CBCT, and 124 with US. Treatment dose of 70.2 Gy was delivered in 26 fractions with a conformal dynamic arcs technique. Interfraction prostate localization errors were determined for the 3 techniques. Moreover, interfraction and intrafraction prostate motion in terms of translations and rotations, as well as residual errors, were determined with X-ray. Results The systematic and random components of the prostate localization errors were as follows: ( 1 ) with X-ray 3.0 ± 3.4, 2.3 ± 2.7, 1.8 ± 2.3 mm in anterior-posterior (AP), superior-inferior (SI), and left-right (LR) directions and 1.8° ± 1.2°, 2.3° ± 1.5°, 2.7° ± 3.1°, for the yaw, roll, and pitch rotations; ( 2 ) with CBCT3.5 ± 4.2, 3.3 ± 3.3, 2.5 ± 3.1 mm in AP, SI, and LR directions; ( 3 ) with US 3.7 ± 4.7, 3.4 ± 4.3, 2.3 ± 3.5 mm in AP, SI, and LR directions. Residual errors with X-ray were less than 1 mm in all directions. Intrafraction prostate motion of less than 0.5 mm in LR and of the order of 1 mm in AP and SI directions was found. This led to a significant reduction of the margins, potentially important for dose escalation studies. Conclusions Daily on-line IGRT with stereoscopic X-ray imaging allowed a consistent PTV margin reduction considering residual interfraction prostate localization error and intrafraction motion. X-ray offers the best compromise among accuracy, reliability, dose to the patient, and time investment for daily IGRT treatment of prostate.
Collapse
|
13
|
Calculation of planning margins for different verification techniques in radical prostate radiotherapy. JOURNAL OF RADIOTHERAPY IN PRACTICE 2014. [DOI: 10.1017/s1460396913000101] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
Abstract
AbstractPurposeTo calculate and compare planning target volume (PTV) margins for an offline 3 mm tolerance, daily bony anatomy verification, tattoo alignment and online prostate marker matching with those currently used at our institution.MethodsSeventy patients had offline bony anatomy megavoltage verification. 23 different patients underwent fiducial marker matching using daily online kilovoltage verification. Systematic and random errors were measured in the right–left (RL), superior–inferior (SI) and anterior–posterior (AP) directions. Geometric uncertainties from literature were used to help calculate the margins.ResultsPTV margins (mm) were 7 RL, 12 SI and AP (3 mm tolerance offline bony), 6 RL, 11 SI and AP (daily online bony), 8 RL, 12 SI and AP (tattoo alignment) and 5 RL, 8 SI and 6 AP (online daily prostate marker correction).ConclusionsOur current margins for conformal radiotherapy patients are too small for phase 2 in the SI and AP directions. Implementing online daily bony anatomy matching would not reduce the PTV margin significantly. Online daily marker correction showed current PTV71 Gy margins as excessive by (mm) 5 RL, 2 SI and 4 anterior.
Collapse
|
14
|
Ikeda I, Mizowaki T, Sawada Y, Nakata M, Norihisa Y, Ogura M, Hiraoka M. Assessment of interfractional prostate motion in patients immobilized in the prone position using a thermoplastic shell. JOURNAL OF RADIATION RESEARCH 2014; 55:168-174. [PMID: 23860549 PMCID: PMC3885122 DOI: 10.1093/jrr/rrt089] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 03/04/2013] [Revised: 06/06/2013] [Accepted: 06/08/2013] [Indexed: 06/02/2023]
Abstract
The aim of this study was to evaluate the interfractional prostate motion of patients immobilized in the prone position using a thermoplastic shell. A total of 24 patients with prostate calcifications detectable using a kilo-voltage X-ray image-guidance system (ExacTrac X-ray system) were examined. Daily displacements of the calcification within the prostate relative to pelvic bony structures were calculated by the ExacTrac X-ray system. The average displacement and standard deviation (SD) in each of the left-right (LR), anterior-posterior (AP), and superior-inferior (SI) directions were calculated for each patient. Based on the results of interfractional prostate motion, we also calculated planning target volume (PTV) margins using the van Herk formula and examined the validity of the PTV margin of our institute (a 9-mm margin everywhere except posteriorly, where a 6-mm margin was applied). In total, 899 data measurements from 24 patients were obtained. The average prostate displacements ± SD relative to bony structures were 2.8 ± 3.3, -2.0 ± 2.0 and 0.2 ± 0.4 mm, in the SI, AP and LR directions, respectively. The required PTV margins were 9.7, 6.1 and 1.4 mm in the SI, AP and LR directions, respectively. The clinical target volumes of 21 patients (87.5%) were located within the PTV for 90% or more of all treatment sessions. Interfractional prostate motion in the prone position with a thermoplastic shell was equivalent to that reported for the supine position. The PTV margin of our institute is considered appropriate for alignment, based on bony structures.
Collapse
Affiliation(s)
- Itaru Ikeda
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
| | - Takashi Mizowaki
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
| | - Yohei Sawada
- Division of Clinical Radiology Service, Kyoto University Hospital, 54 ShogoinKawahara-cho,Sakyo-ku, Kyoto 606-8507, Japan
| | - Manabu Nakata
- Division of Clinical Radiology Service, Kyoto University Hospital, 54 ShogoinKawahara-cho,Sakyo-ku, Kyoto 606-8507, Japan
| | - Yoshiki Norihisa
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
| | - Masakazu Ogura
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
| | - Masahiro Hiraoka
- Department of Radiation Oncology and Image-applied Therapy, Kyoto University Graduate School of Medicine, 54 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
| |
Collapse
|
15
|
Steiner E, Georg D, Goldner G, Stock M. Prostate and Patient Intrafraction Motion: Impact on Treatment Time-Dependent Planning Margins for Patients With Endorectal Balloon. Int J Radiat Oncol Biol Phys 2013; 86:755-61. [DOI: 10.1016/j.ijrobp.2013.02.035] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2012] [Revised: 02/14/2013] [Accepted: 02/27/2013] [Indexed: 10/26/2022]
|
16
|
Hernández TG, González AV, Peidro JP, Ferrando JVR, González LB, Cabañero DG, Torrecilla JL. Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer. Rep Pract Oncol Radiother 2013; 18:265-71. [PMID: 24416563 DOI: 10.1016/j.rpor.2012.12.006] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/20/2012] [Revised: 07/23/2012] [Accepted: 12/30/2012] [Indexed: 10/27/2022] Open
Abstract
BACKGROUND To make a radiobiological comparison, for high risk prostate cancer (T3a, PSA > 20 ng/ml or Gleason > 7) of two radiotherapy treatment techniques. One technique consists of a treatment in three phases of the pelvic nodes, vesicles and prostate using a conventional fractionation scheme of 2 Gy/fraction (SIMRT). The other technique consists of a treatment in two phases that gives simultaneously different dose levels in each phase, 2 Gy/fraction, 2.25 Gy/fraction and 2.5 Gy/fraction to the pelvic nodes, vesicles and prostate, respectively (SIBIMRT). MATERIALS AND METHODS The equivalent dose at fractionation of 2 Gy (EQD2), calculated using the linear quadratic model with α/β prostate = 1.5 Gy, was the same for both treatment strategies. For comparison the parameters employed were D95, mean dose and Tumour Control Probabilities for prostate PTV and D15, D25, D35, D50, mean dose and Normal Tissue Complication Probabilities for the rectum and bladder, with physical doses converted to EQD2. Parameters were obtained for α/β prostate = 1.5, 3 and 10 Gy and for α/β oar = 1, 2, 3, 4, 6 and 8. RESULTS For prostate PTV, both treatment strategies are equivalent for α/β prostate = 1.5 Gy but for higher α/β prostate, EQD2 and TCP, decrease for the SIBIMRT technique. For the rectum and bladder when α/β oar ≤ 2 Gy, EQD2 and NTCP are lower for the SIMRT technique or equal in both techniques. For α/β oar ≥ 2-3 Gy, EQD2 and NTCP increase for the SIMRT treatment. CONCLUSIONS A comparison between two radiotherapy techniques is presented. The SIBIMRT technique reduces EQD2 and NTCP for α/β oar from 2 to 8 Gy.
Collapse
Affiliation(s)
- Trinitat García Hernández
- Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain
| | - Aurora Vicedo González
- Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain
| | - Jorge Pastor Peidro
- Clinical Radiotherapy Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain
| | - Juan V Roselló Ferrando
- Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain
| | - Luis Brualla González
- Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain
| | - Domingo Granero Cabañero
- Radiotherapy Physics Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain
| | - José López Torrecilla
- Clinical Radiotherapy Department, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain
| |
Collapse
|
17
|
Udrescu C, Mornex F, Tanguy R, Chapet O. ExacTrac Snap Verification: A New Tool for Ensuring Quality Control for Lung Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys 2013; 85:e89-94. [DOI: 10.1016/j.ijrobp.2012.09.020] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2011] [Revised: 09/13/2012] [Accepted: 09/16/2012] [Indexed: 12/31/2022]
|
18
|
Relationship of imaging frequency and planning margin to account for intrafraction prostate motion: analysis based on real-time monitoring data. Int J Radiat Oncol Biol Phys 2012; 85:700-6. [PMID: 22795802 DOI: 10.1016/j.ijrobp.2012.05.044] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2011] [Revised: 05/09/2012] [Accepted: 05/30/2012] [Indexed: 11/20/2022]
Abstract
PURPOSE Correction for intrafraction prostate motion becomes important for hypofraction treatment of prostate cancer. The purpose of this study was to estimate an ideal planning margin to account for intrafraction prostate motion as a function of imaging and repositioning frequency in the absence of continuous prostate motion monitoring. METHODS AND MATERIALS For 31 patients receiving intensity modulated radiation therapy treatment, prostate positions sampled at 10 Hz during treatment using the Calypso system were analyzed. Using these data, we simulated multiple, less frequent imaging protocols, including intervals of every 10, 15, 20, 30, 45, 60, 90, 120, 180, and 240 seconds. For each imaging protocol, the prostate displacement at the imaging time was corrected by subtracting prostate shifts from the subsequent displacements in that fraction. Furthermore, we conducted a principal component analysis to quantify the direction of prostate motion. RESULTS Averaging histograms of every 240 and 60 seconds for all patients, vector displacements of the prostate were, respectively, within 3 and 2 mm for 95% of the treatment time. A vector margin of 1 mm achieved 91.2% coverage of the prostate with 30 second imaging. The principal component analysis for all fractions showed the largest variance in prostate position in the midsagittal plane at 54° from the anterior direction, indicating that anterosuperior to inferoposterior is the direction of greatest motion. The smallest prostate motion is in the left-right direction. CONCLUSIONS The magnitudes of intrafraction prostate motion along the superior-inferior and anterior-posterior directions are comparable, and the smallest motion is in the left-right direction. In the absence of continuous prostate motion monitoring, and under ideal circumstances, 1-, 2-, and 3-mm vector planning margins require a respective imaging frequency of every 15, 60, and 240 to account for intrafraction prostate motion while achieving adequate geometric target coverage for 95% of the time.
Collapse
|
19
|
Suzuki J, Tateoka K, Shima K, Yaegashi Y, Fujimoto K, Saitoh Y, Nakata A, Abe T, Nakazawa T, Sakata K, Hareyama M. Uncertainty in patient set-up margin analysis in radiation therapy. JOURNAL OF RADIATION RESEARCH 2012; 53:615-619. [PMID: 22843628 PMCID: PMC3393349 DOI: 10.1093/jrr/rrs003] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 11/09/2011] [Accepted: 02/22/2012] [Indexed: 06/01/2023]
Abstract
We investigated the uncertainty in patient set-up margin analysis with a small dataset consisting of a limited number of clinical cases over a short time period, and propose a method for determining the optimum set-up margin. Patient set-up errors from 555 registration images of 15 patients with prostate cancer were tested for normality using a quantile-quantile (Q-Q) plot and a Kolmogorov-Smirnov test with the hypothesis that the data were not normally distributed. The ranges of set-up errors include the set-up errors within the 95% interval of the entire patient data histogram, and their equivalent normal distributions were compared. The patient set-up error was not normally distributed. When the patient set-up error distribution was assumed to have a normal distribution, an underestimate of the actual set-up error occurred in some patients but an overestimate occurred in others. When using a limited dataset for patient set-up errors, which consists of only a small number of the cases over a short period of time in a clinical practice, the 2.5% and 97.5% intervals of the actual patient data histogram from the percentile method should be used for estimating the set-up margin. Since set-up error data is usually not normally distributed, these intervals should provide a more accurate estimate of set-up margin. In this way, the uncertainty in patient set-up margin analysis in radiation therapy can be reduced.
Collapse
Affiliation(s)
- Junji Suzuki
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
- Sapporo IGRT Clinic, 2-11 N30 W14, Kita-ku, Sapporo, 001-0030, Japan
| | - Kunihiko Tateoka
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Katsumi Shima
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Yuji Yaegashi
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Kazunori Fujimoto
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Yuichi Saitoh
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Akihiro Nakata
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Tadanori Abe
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Takuya Nakazawa
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Kouichi Sakata
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| | - Masato Hareyama
- Department of Radiation Oncology and Medical Physics, Graduate School of Medicine, Sapporo Medical University, S1 W6 Chuo-ku, Sapporo, 060-8556, Japan
| |
Collapse
|
20
|
Shi C, Tazi A, Fang DX, Iannuzzi C. Study of ExacTrac X-ray 6D IGRT setup uncertainty for marker-based prostate IMRT treatment. J Appl Clin Med Phys 2012; 13:3757. [PMID: 22584176 PMCID: PMC5716561 DOI: 10.1120/jacmp.v13i3.3757] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2011] [Revised: 01/02/2012] [Accepted: 01/05/2012] [Indexed: 11/23/2022] Open
Abstract
Novalis Tx ExacTrac X-ray system has the 6D adjustment ability for patient setup. Limited studies exist about the setup uncertainty with ExacTrac X-ray system for IMRT prostate treatment with fiducial markers implanted. The purpose of this study is to investigate the marker-based prostate IMRT treatment setup uncertainty using ExacTrac 6D IGRT ability for patient setup. Forty-three patients with prostate cancers and markers implanted have been treated on the Novalis Tx machine. The ExacTrac X-ray system has been used for the patient pretreatment setup and intratreatment verification. In total, the shifts data for 1261 fractions and 3504 correction times (the numbers of X-ray images were taken from tube 1 and tube 2) have been analyzed. The setup uncertainty has been separated into uncertainties in 6D. Marker matching uncertainty was also analyzed. Correction frequency probability density function was plotted, and the radiation dose for imaging was calculated. The minimum, average, and maximum translation shifts were: -5.12 ± 3.89 mm, 0.20 ± 2.21 mm, and 6.07 ± 4.44 mm, respectively, in the lateral direction; -6.80 ± 3.21 mm, -1.09 ± 2.21 mm, and 3.12 ± 2.62 mm, respectively, in the longitudinal direction; and -7.33 ± 3.46 mm, -0.93 ± 2.70 mm, and 5.93 ± 4.85mm, respectively, in the vertical direction. The minimum, average, and maximum rotation shifts were: -1.23° ± 1.95°, 0.25° ± 1.30°, and 2.38° ± 2.91°, respectively, along lateral direction; -0.67° ± 0.91°, 0.10° ± 0.61°, and 1.51° ± 2.04°, respectively, along longitudinal direction; and -0.75° ± 1.01°, 0.02° ± 0.50°, and 0.82° ± 1.13°, respectively, along vertical direction. On average, each patient had three correction times during one fraction treatment. The radiation dose is about 3 mSv per fraction. With the ExacTrac 6D X-ray system, the prostate IMRT treatment with marker implanted can achieve less than 2 mm setup uncertainty in translations, and less than 0.25° in rotations as overall interfraction mean error. The imaging dose is less than kV (CBCT) for setup verification.
Collapse
Affiliation(s)
- Chengyu Shi
- Department of Oncology, St. Vincent’s Medical Center, Bridgeport, CT, USA.
| | | | | | | |
Collapse
|
21
|
Alexander EJ, Harris VA, Sohaib A, Dearnaley D. Reducing the side effects of external beam radiotherapy in prostate cancer: role of imaging techniques. ACTA ACUST UNITED AC 2012. [DOI: 10.2217/iim.11.65] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
22
|
Snir J, Battista J, Bauman G, Yartsev S. Evaluation of Inter-fraction Prostate Motion using Kilovoltage Cone Beam Computed Tomography during Radiotherapy. Clin Oncol (R Coll Radiol) 2011; 23:625-31. [DOI: 10.1016/j.clon.2011.03.007] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/06/2010] [Revised: 01/13/2011] [Accepted: 02/02/2011] [Indexed: 11/24/2022]
|
23
|
EBT2 radiochromic film for quality assurance of complex IMRT treatments of the prostate: micro-collimated IMRT, RapidArc, and TomoTherapy. AUSTRALASIAN PHYSICAL & ENGINEERING SCIENCES IN MEDICINE 2011; 34:333-43. [DOI: 10.1007/s13246-011-0087-z] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/10/2011] [Accepted: 06/28/2011] [Indexed: 11/26/2022]
|
24
|
Graf R, Boehmer D, Budach V, Wust P. Residual translational and rotational errors after kV X-ray image-guided correction of prostate location using implanted fiducials. Strahlenther Onkol 2010; 186:544-50. [PMID: 20936461 DOI: 10.1007/s00066-010-2030-8] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2009] [Accepted: 07/19/2010] [Indexed: 12/25/2022]
Abstract
PURPOSE To evaluate the residual errors and required safety margins after stereoscopic kilovoltage (kV) X-ray target localization of the prostate in image-guided radiotherapy (IGRT) using internal fiducials. PATIENTS AND METHODS Radiopaque fiducial markers (FMs) have been inserted into the prostate in a cohort of 33 patients. The ExacTrac/Novalis Body™ X-ray 6d image acquisition system (BrainLAB AG, Feldkirchen, Germany) was used. Corrections were performed in left-right (LR), anterior-posterior (AP), and superior-inferior (SI) direction. Rotational errors around LR (x-axis), AP (y) and SI (z) have been recorded for the first series of nine patients, and since 2007 for the subsequent 24 patients in addition corrected in each fraction by using the Robotic Tilt Module™ and Varian Exact Couch™. After positioning, a second set of X-ray images was acquired for verification purposes. Residual errors were registered and again corrected. RESULTS Standard deviations (SD) of residual translational random errors in LR, AP, and SI coordinates were 1.3, 1.7, and 2.2 mm. Residual random rotation errors were found for lateral (around x, tilt), vertical (around y, table), and longitudinal (around z, roll) and of 3.2°, 1.8°, and 1.5°. Planning target volume (PTV)-clinical target volume (CTV) margins were calculated in LR, AP, and SI direction to 2.3, 3.0, and 3.7 mm. After a second repositioning, the margins could be reduced to 1.8, 2.1, and 1.8 mm. CONCLUSION On the basis of the residual setup error measurements, the margin required after one to two online X-ray corrections for the patients enrolled in this study would be at minimum 2 mm. The contribution of intrafractional motion to residual random errors has to be evaluated.
Collapse
Affiliation(s)
- Reinhold Graf
- Department of Radiation Oncology, Charite - University Medicine Berlin, Campus Virchow-Klinikum, Berlin, Germany
| | | | | | | |
Collapse
|
25
|
Giordani AJ, Dias RS, Segreto HRC, Segreto RA. Acurácia na reprodutibilidade do posicionamento diário de pacientes submetidos a radioterapia conformada (RT3D) para câncer de próstata. Radiol Bras 2010. [DOI: 10.1590/s0100-39842010000400007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
OBJETIVO: Avaliar a reprodutibilidade do posicionamento de pacientes com diagnóstico de câncer de próstata submetidos a radioterapia conformada. MATERIAIS E MÉTODOS: Foram avaliados 960 (posições anterior e lateral) filmes radiológicos, de um total de 120 pacientes que receberam radioterapia conformada na próstata com técnica isocêntrica. As imagens foram obtidas em acelerador linear de partículas 6 MV. Aplicou-se protocolo específico para planejamento e tratamento da próstata, com o paciente em posição supina, mãos colocadas sobre o tórax, pés apoiados em suporte apropriado. Diariamente, os pacientes foram posicionados conforme demarcações na pele, coincidentes com os lasers da sala. Os filmes radiológicos foram comparados com as radiografias reconstruídas digitalmente (digitally reconstructed radiography - DRR) em sistema de planejamento computadorizado Eclipse, a partir das tomografias. As radiografias de posicionamento foram realizadas no primeiro dia e após, semanalmente, até o término do tratamento. RESULTADOS: As médias dos deslocamentos observados foram de 1,99 ± 1,25 mm no sentido crânio-caudal, 1,37 ± 0,84 mm no látero-lateral e 1,94 ± 1,10 mm no ântero-posterior. CONCLUSÃO: O uso de protocolos específicos para posicionamento dos pacientes é possível na prática clínica, possibilita reprodutibilidade adequada e rápida correção dos possíveis erros.
Collapse
|
26
|
A Prospective Study of Intrafraction Prostate Motion in the Prone vs. Supine Position. Int J Radiat Oncol Biol Phys 2010; 77:165-70. [DOI: 10.1016/j.ijrobp.2009.04.041] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2008] [Revised: 04/22/2009] [Accepted: 04/23/2009] [Indexed: 11/20/2022]
|
27
|
Lips IM, van der Heide UA, Kotte AN, van Vulpen M, Bel A. Effect of Translational and Rotational Errors on Complex Dose Distributions With Off-Line and On-Line Position Verification. Int J Radiat Oncol Biol Phys 2009; 74:1600-8. [DOI: 10.1016/j.ijrobp.2009.02.056] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/24/2008] [Revised: 02/19/2009] [Accepted: 02/24/2009] [Indexed: 11/30/2022]
|
28
|
Gauthier I, Carrier JF, Béliveau-Nadeau D, Fortin B, Taussky D. Dosimetric Impact and Theoretical Clinical Benefits of Fiducial Markers for Dose Escalated Prostate Cancer Radiation Treatment. Int J Radiat Oncol Biol Phys 2009; 74:1128-33. [DOI: 10.1016/j.ijrobp.2008.09.043] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2008] [Revised: 09/01/2008] [Accepted: 09/06/2008] [Indexed: 11/16/2022]
|
29
|
Chino K, Tanyi JA, Stea B. Stereotactic Radiotherapy for Unilateral Orbital Lymphoma and Orbital Pseudo-Tumors: A Planning Study. Med Dosim 2009; 34:57-62. [DOI: 10.1016/j.meddos.2007.12.004] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/20/2007] [Revised: 11/28/2007] [Accepted: 12/27/2007] [Indexed: 10/22/2022]
|
30
|
Johnston H, Hilts M, Beckham W, Berthelet E. 3D ultrasound for prostate localization in radiation therapy: A comparison with implanted fiducial markers. Med Phys 2008; 35:2403-13. [DOI: 10.1118/1.2924208] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|